In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Practice Guideline Track on ACS

Guidelines into Practice

Acute Coronary Syndromes (ACS)
Chronic Ischaemic Heart Disease (IHD)


Contributors: Special thanks to Susanna Price and Christiaan Vrints from the Acute Cardiovascular Care Association

Based on the 2012 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Part 1 - Overview of the ESC 2012 Guidelines on Acute myocardial infarction, STEMI

Session Presentation Title Slides Webcast
New 2012 ESC guidelines for acute myocardial infarction ST elevation


Early management and reperfusion strategies    

Primary percutaneous coronary intervention and adjunctive pharmacology
   
Thrombolysis, adjunctive pharmacology and interventions    
Subsequent management and therapies    
Third universal definition MI: Infarction acute phase STEMI What's new in the third universal definition?      
 
Myocardial infarction type 2: persistent uncertainties
     
High-sensitivity troponins: strengths and pitfalls      
Use of myocardial infarction definitions in clinical trials      

 

Part 2 - Topics in focus

Topic Presentation Title Slides  Webcast
 

Acute assessment & networks






The current situation and experience of ST-elevation myocardial infarction reperfusion therapy in China and Europe
Treatment of ST-elevation myocardial infarction in Europe.    
Chest pain units in Europe.    
The treatment of ST-elevation myocardial infarction in China: where are we?    
The experience of chest pain centres: in China, what have we got?    
Assessing the patient with acute chest pain
Clinical and echocardiography assessment: tips and tricks.     
Role of biomarkers.     
Cardiac magnetic resonance.     
Computed tomography.     
 

Antithrombotic & antiplatelet agents



 
 New evidence, new approaches: optimising long-term management of acute coronary syndromes
Welcome and introduction.     
Oral antiplatelet therapy in acute coronary syndromes: what is the evidence supporting long-term benefits     
Re-assessing the role of clopidogrel in the management of acute coronary syndromes: the changing landscape in oral antiplatelet therapy.     
Risk stratifaction in acute coronary syndromes: is there still room for improvement?     
Pleiotropic effects: potential benefits of oral antiplatelet therapy beyond P2Y12 receptor antagonism.     
 The new frontiers of the pharmacological intervention in acute coronary syndromes
 Prescribing antiplatelet therapy in acute coronary syndrome: how and for whom the selection should be made?     
Managing antiplatelet therapy in patients with renal dysfunction, previous stroke, atrial fibrillation and undergoing CABG.     
What is the best antithrombin regimen for non ST-elevation myocardial infarction patients?     
Update on antithrombotics in acute coronary syndromes
P2Y12 blockade. To load or not to load before the cath lab?      

Oral anti-Xa agents. A new opportunity?
     
Thrombus aspiration. The best antithrombotic?      
 PCI Burning issues in percutaneous coronary imaging for acute coronary syndromes
Role of risk scores.     
Should non ST-elevation myocardial infarction be treated as rapidly as ST-elevation myocardial infarction?     
Stent for life: optimising primary percutaneous coronary intervention in Europe
 Primary percutaneous coronary intervention is cost-effective.
 
    
 Stepwise regional implementation.     
 Networking decreases mortality.     
 Balloon? Stents? When? How? Why?
 Drug eluting balloon for instent restenosis.      
 Optimal bifurcation stenting.      
 The big 5 in percutaneous coronary intervention    
 Primary percutaneous coronary intervention.      
 Multivessel percutaneous coronary intervention.      
 Left main percutaneous coronary intervention      
 Bifurcation percutaneous coronary intervention.      
Chronic total occlusion.      
PROTECT
PROTECT: Primary Results from PROTECT: the Patient Related Outcomes with Endeavor versus Cypher Stenting Trial      
 Discussant: PROTECT: Primary Results from PROTECT: the Patient Related Outcomes with Endeavor versus Cypher Stenting Trial      
 Mechanical support  IABP-SHOCK II: Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock      
 Discussant: IABP-SHOCK II: Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock      
Cardiogenic shock  Treatment of post myocardial infarction cardiogenic shock : Panel.     
Registries  FAST-MI programme: Decrease in early mortality in STEMI is related to changing patient profile and behavior, as well as improved organization of care: Data from 4 French nationwide surveys over 15 year      
GRACE: Effects of Insulin Glargin and of Polyunsaturated Fatty Acids on Carotid Intima Media Thickness in High-Risk Diabetes      
Translational medicine Pathophysiology of ischaemia-reperfusion injury      
Prevention of microvascular obstruction      
Pre-hospital ECG: benefits and difficulties      
Optimal antithrombotic therapy: upstream and during primary percutaneous coronary intervention      
Gender differences in daytime and night-time blood pressure variability and their prognostic relevance. Dublin Outcome Study      
Absolute nocturnal blood pressure values outweigh nondipping pattern in the prediction of stroke and atrial fibrillation: data from a follow up study      
A multicenter, prospective, randomised, open-labeled, trial comparing different bone-marrow-derived stem cell approaches in patients with reperfused ST-elevation myocardial infarction